CDP791

CDP791 · UCB Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CDP791, covering 2022-04-12 to 2022-04-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer [Phase 2]